-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Talis Biomedical Corp quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2020 to Q2 2024.
- Talis Biomedical Corp Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$8.85M, a 41.1% increase year-over-year.
- Talis Biomedical Corp Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$51M, a 40.5% increase year-over-year.
- Talis Biomedical Corp annual Net Income (Loss) Attributable to Parent for 2023 was -$62M, a 45.1% increase from 2022.
- Talis Biomedical Corp annual Net Income (Loss) Attributable to Parent for 2022 was -$113M, a 41.2% increase from 2021.
- Talis Biomedical Corp annual Net Income (Loss) Attributable to Parent for 2021 was -$192M, a 111% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)